chat icon

WhatsApp Expert

Book Free Consult

ZenOnco.io Earns Global Recognition at ESMO Congress for Pioneering AI-Based Cancer Care Tool

Sep 21, 2020
 ZenOnco.io Earns Global Recognition at ESMO Congress for Pioneering AI-Based Cancer Care Tool
Mumbai, Maharashtra, India – ZenOnco.io, an innovative integrative oncology healthtech platform based in Mumbai, has gained international acclaim at the European Society for Medical Oncology (ESMO) Annual Virtual Congress. The platform was recognized for its pioneering development: the world's first artificial intelligence-based tool to generate free directional cancer treatment assessment reports.

Revolutionizing Cancer Care with AI Technology
The AI-based tool developed by ZenOnco.io marks a significant breakthrough in cancer care. It provides patients with complimentary access to artificial intelligence-generated reports that offer insights into possible treatment options, encompassing both medical and complementary treatment approaches. This innovation is a step forward in making comprehensive cancer care more accessible and tailored to individual patient needs.

Global Recognition at ESMO Annual Virtual Congress
The acknowledgment of ZenOnco.io at the ESMO Annual Virtual Congress, a leading event in the field of medical oncology, underscores the global impact of this innovation. The platform's recognition at this prestigious international forum highlights its commitment to enhancing cancer care through technology.

A Commitment to Integrative Cancer Care
Dimple Parmar, Founder & CEO and Kishan Shah, co-founder & CFO of ZenOnco.io, expressed pride in the recognition, stating, “Being recognized globally at the ESMO Annual Virtual Congress 2020 is a testimony to our dedication to making quality integrative cancer care accessible to all.” This statement reflects the core mission of ZenOnco.io to bridge the gap between traditional and complementary cancer treatments, ensuring patients receive holistic care.

Paving the Way for Future Innovations in Oncology
The international acclaim received by ZenOnco.io at the ESMO Congress not only celebrates its current achievements but also sets the stage for future innovations in the field of oncology. It exemplifies how technology, specifically AI, can play a transformative role in cancer treatment and patient care.

ZenOnco.io's achievement at the ESMO Annual Virtual Congress represents a significant milestone in the journey towards advanced, accessible, and integrative cancer care. It highlights the Mumbai-based platform's role as a leader in healthcare technology and its unwavering commitment to improving the lives of cancer patients globally.

Ready for the better cancer care experience

We're here to help you. Contact ZenOnco.io at [email protected] or call +91 99 3070 9000 for any assistance